Ou, Xiaomin
Yan, Wenbin
Huang, Yangle
He, Xiayun
Ying, Hongmei
Lu, Xueguan
Zhu, Hui
Wu, Bin
Wang, Jiazhou
Hu, Chaosu
Funding for this research was provided by:
National Natural Science Foundation of China (81602372)
Chinese Society of Clinical Oncology (Y-Young2021-0127)
Article History
Received: 1 December 2022
Accepted: 2 January 2023
First Online: 21 March 2023
Declarations
:
: The study protocol was approved by the Institutional Review Board (IRB) of Fudan University Shanghai Cancer Center (2208258-14) according to the principles of the Declaration of Helsinki. The informed consent was waived by the IRB due to the retrospective nature, minimal risk to participants and secondary analysis of previous project.
: The authors declare that they have no competing interests.